BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valiyari S, Salimi M, Bouzari S. Novel fusion protein NGR-sIL-24 for targetedly suppressing cancer cell growth via apoptosis. Cell Biol Toxicol 2020;36:179-93. [PMID: 32239369 DOI: 10.1007/s10565-020-09519-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ilangala AB, Lechanteur A, Fillet M, Piel G. Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems. Eur J Pharm Biopharm 2021;167:140-58. [PMID: 34311093 DOI: 10.1016/j.ejpb.2021.07.010] [Reference Citation Analysis]
2 Li T, Zhang HZ, Ge GF, Yue ZR, Wang RY, Zhang Q, Gu Y, Song MJ, Li WB, Ma MZ, Wang MZ, Yang H, Li Y, Li HY. Albumin Fusion at the N-Terminus or C-Terminus of HM-3 Leads to Improved Pharmacokinetics and Bioactivities. Biomedicines 2021;9:1084. [PMID: 34572270 DOI: 10.3390/biomedicines9091084] [Reference Citation Analysis]
3 Al-Mansoori L, Elsinga P, Goda SK. Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy. Biomed Pharmacother 2021;144:112260. [PMID: 34607105 DOI: 10.1016/j.biopha.2021.112260] [Reference Citation Analysis]
4 Gong W, Liang Y, Mi J, Jia Z, Xue Y, Wang J, Wang L, Zhou Y, Sun S, Wu X. Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium Tuberculosis Infection in a Humanized Mouse Model. Front Immunol 2021;12:666290. [PMID: 33981313 DOI: 10.3389/fimmu.2021.666290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li X, Fu H, Wang J, Liu W, Deng H, Zhao P, Liao W, Yang Y, Wei H, Yang X, Chen Y. Multimodality labeling of NGR-functionalized hyaluronan for tumor targeting and radiotherapy. Eur J Pharm Sci 2021;161:105775. [PMID: 33640501 DOI: 10.1016/j.ejps.2021.105775] [Reference Citation Analysis]
6 Zorko M, Jones S, Langel Ü. Cell-penetrating peptides in protein mimicry and cancer therapeutics. Adv Drug Deliv Rev 2021;180:114044. [PMID: 34774552 DOI: 10.1016/j.addr.2021.114044] [Reference Citation Analysis]